| Citation: |
ZHAO Yan, YANG Hua, LIU Yun, ZHANG Yan, Wang Xin'ai. Clinical efficacy of Huazhuo Tongqing Decoction in treating chronic atrophic gastritis with internal accumulation of turbidity and poison[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 58-62. DOI: 10.7619/jcmp.20233786
|
To explore the clinical effect of Huazhuo Tongqing Yin in treating chronic atrophic gastritis (CAG) with internal accumulation of turbidity and poison.
A total of 159 patients with CAG were randomly divided into traditional Chinese medicine group, western medicine group and control group, and were given Huazhuo Tongqing Decoction, rabeprazole sodium enteric-coated tablets and morodan, respectively. Clinical efficacy, TCM syndromes, pathological changes, 36-item Short-form Health Status Survey(SF-36) score and serum gastrin-17 (G-17) and prostaglandin E2 (PGE2) before and after treatment were compared.
The total effective rate was 92.45% in Chinese medicine group, 62.26% in western medicine group and 66.04% in control group. After three months of treatment, the scores of epigastric pain, gastric distension and discomfort, acid regurgitation and heartburn, belching, and stool stickiness in the three groups were all lower than those before treatment, and the scores of epigastric pain, gastric distension and discomfort, acid regurgitation and heartburn, belching, and sticky stool in the traditional Chinese medicine group were lower than those in the control group andthe western medicine group (P < 0.05). The SF-36 scores of the three groups at 1-, 2-, 3-month improved after treatment, and the SF-36 score of the traditional Chinese medicine group was higher than that of the control group and the western medicine group (P < 0.05). During follow-up, the SF-36 score of the traditional Chinese medicine group was still higher than those of the control group and the western medicine group (P < 0.05). After treatment, the serum levels of G-17 and PGE2 in the three groups were higher thanthose before treatment, and were higher in the traditional Chinese medicine group than those in the western medicine group and the control group (P < 0.05). No adverse reactions occurred in any of the three groups during treatment.
Huazhuo Tongqing Decoction can alleviate the symptoms of CAG, improve the pathological state and the quality of life.
| [1] |
袁成业, 肖建国, 陈林伟, 等. 慢性萎缩性胃炎中医诊治难点分析及对策[J]. 中华中医药杂志, 2021, 36(1): 292-295. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202101075.htm
|
| [2] |
陈稀烦, 骆瑛, 张丹. 参芪健胃颗粒对脾胃虚寒证慢性萎缩性胃炎患者的胃肠激素及氧化应激状况的影响[J]. 中国药物与临床, 2020, 20(1): 1-5. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202001001.htm
|
| [3] |
时艳华, 任喜尚, 秦芳, 等. 扶正消萎汤治疗脾胃虚弱型慢性萎缩性胃炎的临床观察[J]. 中华中医药学刊, 2020, 38(5): 86-88. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202005020.htm
|
| [4] |
王春, 陈丽康, 陈梦梦, 等. 自拟调胃汤对慢性萎缩性胃炎患者MTL和SS的影响[J]. 中药材, 2021, 44(11): 2707-2710. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCA202111040.htm
|
| [5] |
中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年, 上海)[J]. 胃肠病学, 2017, 22(11): 670-687. https://xuewen.cnki.net/CCND-JFRB202402240013.html
|
| [6] |
张声生, 李乾构, 唐旭东, 等. 慢性萎缩性胃炎中医诊疗共识意见[J]. 中医杂志, 2010, 51(8): 749-753. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201008037.htm
|
| [7] |
张声生, 刘凤斌, 侯政昆. 脾胃病症状量化标准专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(8): 3590-3596. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201708072.htm
|
| [8] |
刘新桥, 王玲. 正气散加减治疗慢性胃炎对患者生活质量、炎性因子水平的影响[J]. 中国中药杂志, 2019, 44(1): 181-185. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201901026.htm
|
| [9] |
郑筱萸. 中药新药临床研究指导原则(试行)[S]. 北京: 中国医药科技出版社, 2002: 125-129.
|
| [10] |
强薇, 贾如冰, 毕玮, 等. 胃复春片联合兰索拉唑肠溶片对慢性萎缩性胃炎患者血清胃肠激素、炎症因子及免疫功能的影响[J]. 现代生物医学进展, 2021, 21(21): 4066-4069, 4162. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202121013.htm
|
| [11] |
王丽园, 成映霞, 段永强, 等. 香砂六君子汤对慢性萎缩性胃炎大鼠的作用研究[J]. 中国临床药理学杂志, 2020, 36(3): 318-321. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202003030.htm
|
| [12] |
杨萍, 李立娟, 刘竺华. 慢性萎缩性胃炎的中医药诊治研究进展[J]. 光明中医, 2022, 37(14): 2661-2663. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202214062.htm
|
| [13] |
陈淑玲, 韩亮. 败酱草的现代研究进展[J]. 广东药科大学学报, 2017, 33(6): 816-821. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYX201706035.htm
|
| [14] |
谢士敏, 周长征. 蒲公英药理作用及临床应用研究进展[J]. 辽宁中医药大学学报, 2020, 22(5): 138-142. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB202005034.htm
|
| [15] |
赖晓峰. 砂仁促进胃部疾病患者胃肠功能恢复的临床研究[J]. 哈尔滨医药, 2021, 41(3): 136-137. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYY202103069.htm
|
| [16] |
NAM H H, KIM J S, LEE J, et al. Pharmacological effects of Agastache rugosa against gastritis using a network pharmacology approach[J]. Biomolecules, 2020, 10(9): 1298. doi: 10.3390/biom10091298
|
| [17] |
李庭树, 黄锁义. 鸡骨草的化学成分、药理作用及临床应用研究进展[J]. 中国实验方剂学杂志, 2019, 25(10): 226-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201910032.htm
|
| [18] |
景永帅, 张钰炜, 张丹参, 等. 大腹皮本草考证、化学成分和药理作用研究进展[J]. 中国药房, 2021, 32(14): 1784-1788. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA202114021.htm
|
| [19] |
吴佳莹, 吴威, 杜佳蓉, 等. 石菖蒲本草考证[J]. 辽宁中医药大学学报, 2022, 24(5): 148-156. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB202205030.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: